# ATC code H02

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/ATC_code_H02
> Markdown URL: https://mediated.wiki/source/ATC_code_H02.md
> Source: https://en.wikipedia.org/wiki/ATC_code_H02
> Source revision: 1190488462
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

Pharmaceutical drug classification

ATC code H: Systemic hormonal preparations, excluding sex hormones and insulins H01 Pituitary and hypothalamic hormones and analogues H02 Corticosteroids for systemic use H03 Thyroid therapy H04 Pancreatic hormones H05 Calcium homeostasis Other ATC codes A B C D G H QI J L M N P R S V

**ATC code H02** *Corticosteroids for systemic use* is a therapeutic subgroup of the [Anatomical Therapeutic Chemical Classification System](/source/Anatomical_Therapeutic_Chemical_Classification_System), a system of alphanumeric codes developed by the [World Health Organization](/source/World_Health_Organization) (WHO) for the classification of [drugs](/source/Pharmaceutical_drug) and other medical products.[1][2][3] Subgroup H02 is part of the anatomical group [H *Systemic hormonal preparations, excluding sex hormones and insulins*](/source/ATC_code_H).[4]

Codes for [veterinary](/source/Veterinary) use ([ATCvet codes](/source/ATCvet_code)) can be created by placing the letter Q in front of the human ATC code: for example, **QH02**.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list. National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

## H02A Corticosteroids for systemic use, plain

### H02AA Mineralocorticoids

- H02AA01 [Aldosterone](/source/Aldosterone)

- H02AA02 [Fludrocortisone](/source/Fludrocortisone)

- H02AA03 [Desoxycortone](/source/Desoxycortone)

### H02AB Glucocorticoids

- H02AB01 [Betamethasone](/source/Betamethasone)

- H02AB02 [Dexamethasone](/source/Dexamethasone)

- H02AB03 [Fluocortolone](/source/Fluocortolone)

- H02AB04 [Methylprednisolone](/source/Methylprednisolone)

- H02AB05 [Paramethasone](/source/Paramethasone)

- H02AB06 [Prednisolone](/source/Prednisolone)

- H02AB07 [Prednisone](/source/Prednisone)

- H02AB08 [Triamcinolone](/source/Triamcinolone)

- H02AB09 [Hydrocortisone](/source/Hydrocortisone)

- H02AB10 [Cortisone](/source/Cortisone)

- H02AB11 [Prednylidene](/source/Prednylidene)

- H02AB12 [Rimexolone](/source/Rimexolone)

- H02AB13 [Deflazacort](/source/Deflazacort)

- H02AB14 [Cloprednol](/source/Cloprednol)

- H02AB15 [Meprednisone](/source/Meprednisone)

- H02AB17 [Cortivazol](/source/Cortivazol)

- H02AB18 [Vamorolone](/source/Vamorolone)

- QH02AB30 Combinations of glucocorticoids

- QH02AB56 Prednisolone, combinations

- QH02AB57 Prednisone, combinations

- QH02AB90 [Flumetasone](/source/Flumetasone)

## H02B Corticosteroids for systemic use, combinations

### H02BX Corticosteroids for systemic use, combinations

- H02BX01 Methylprednisolone, combinations

- QH02BX90 Dexamethasone, combinations

## H02C Antiadrenal preparations

### H02CA Anticorticosteroids

- H02CA01 [Trilostane](/source/Trilostane)

- H02CA02 [Osilodrostat](/source/Osilodrostat)

- H02CA03 [Ketoconazole](/source/Ketoconazole)

- H02CA04 [Levoketoconazole](/source/Levoketoconazole)

## References

1. **[^](#cite_ref-1)** ["ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis"](https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/ATC/index.html). *[National Institutes of Health](/source/National_Institutes_of_Health)*. Retrieved 1 February 2020.

1. **[^](#cite_ref-2)** ["Anatomical Therapeutic Chemical (ATC) Classification"](https://www.who.int/tools/atc-ddd-toolkit/atc-classification). *[World Health Organization](/source/World_Health_Organization)*. Retrieved 3 January 2022.

1. **[^](#cite_ref-3)** ["Structure and principles"](https://www.whocc.no/atc/structure_and_principles/). *WHO Collaborating Centre for Drug Statistics Methodology*. 15 February 2018. Retrieved 3 January 2022.

1. **[^](#cite_ref-4)** ["ATC/DDD Index 2022: code H02"](http://www.whocc.no/atc_ddd_index/?code=H02). *WHO Collaborating Centre for Drug Statistics Methodology*.

1. **[^](#cite_ref-5)** ["ATCvet Index 2022: code QH02"](http://www.whocc.no/atcvet/atcvet_index/?code=H02). *WHO Collaborating Centre for Drug Statistics Methodology*.

v t e Mineralocorticoids and antimineralocorticoids (H02) Mineralocorticoids 11-Deoxycorticosterone (desoxycortone) 11-Deoxycortisol (cortodoxone) Aldosterone Corticosterone Cortisol (hydrocortisone) Desoxycortone acetate Desoxycortone enanthate Fludrocortisone Fludrocortisone acetate Antimineralocorticoids Amlodipine Benidipine Canrenoate potassium (potassium canrenoate) Canrenoic acid Canrenone Drospirenone Eplerenone Felodipine Finerenone Gestodene Nifedipine Nimodipine Nitrendipine Progesterone Spironolactone Synthesis modifiers Acetoxolone Aminoglutethimide Carbenoxolone Enoxolone Ketoconazole Metyrapone Mitotane Osilodrostat Trilostane #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III

---
Adapted from the Wikipedia article [ATC code H02](https://en.wikipedia.org/wiki/ATC_code_H02) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/ATC_code_H02?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.